Results 201 to 210 of about 39,639 (239)

CD73 induces gemcitabine resistance in pancreatic ductal adenocarcinoma: A promising target with non-canonical mechanisms

Cancer Letters, 2021
Shengyu Yang, Jihui Hao, Ying Ma
exaly  

CD73 INHIBITORS

2019
DALLY ROBERT DEAN, GARCIA PAREDES MARIA CRISTINA, HEINZ LAWRENCE JOSEPH II, HOWELL JENNIFER MARIE, NJOROGE FRANK GEORGE, WANG YAN, ZHAO GENSHI   +6 more
openaire   +9 more sources

Co-inhibition of CD73 and A2AR Adenosine Signaling Improves Anti-tumor Immune Responses

Cancer Cell, 2016
Mark J. Smyth, Deborah S Barkauskas, Kazuyoshi Takeda   +2 more
exaly  

Clinical significance of CD73 in triple-negative breast cancer: multiplex analysis of a phase III clinical trial

Annals of Oncology, 2018
John Stagg, Laurence Buisseret, L Ameye
exaly  

CD73 acts as a prognostic biomarker and promotes progression and immune escape in pancreatic cancer

Journal of Cellular and Molecular Medicine, 2020
Wenhui Lou, Wenchuan Wu, Ning Pu
exaly  

High expression of CD73 as a poor prognostic biomarker in human colorectal cancer

Journal of Surgical Oncology, 2012
Xiaojian Wu, Ping Lan, Lei Lian
exaly  

Anti-CD73 therapy impairs tumor angiogenesis

International Journal of Cancer, 2014
John Stagg, Bertrand Allard, Isabelle Royal   +2 more
exaly  

Anti-CD73 in Cancer Immunotherapy: Awakening New Opportunities

Trends in Cancer, 2016
Gennady Yegutkin, Pal Pacher, Corrado Blandizzi   +2 more
exaly  

CD73 COMPOUNDS

2023
BARTLETT MARK J, CHIN GREGORY F, CLARKE MICHAEL O, COSMAN JENNIFER L, ENSAN DEEBA, GOYAL BINDU, HO STEPHEN, MACKMAN RICHARD L, MISH MICHAEL R, SIEGEL DUSTIN S, TAMSHEN KYLE C, YANG HAI   +11 more
openaire   +1 more source

Blocking Antibodies Targeting the CD39/CD73 Immunosuppressive Pathway Unleash Immune Responses in Combination Cancer Therapies

Cell Reports, 2019
Laurent Gros, Eric Vivier, Armand Bensussan   +2 more
exaly